AML |
Acute myeloid leukemia |
AP-MS |
Affinity purification mass spectrometry |
CDK2AP1 |
Cyclin-dependent kinase 2-associated protein 1 |
CFDA |
Chinese Food and Drug Administration |
CHD |
Chromodomain helicase DNA‑binding protein |
CNS |
Central nervous system |
CoREST |
Corepressor of RE1-silencing transcription |
Cryo-EM |
Cryo-electron microscopy |
DLBCL |
Diffuse large B-cell lymphoma |
DNTTIP1 |
Deoxynucleotidyl-transferase terminal-interacting protein 1 |
EM |
Electron microscopy |
FDA |
Food and Drug Administration |
GPS |
G-protein pathway suppressor |
HDAC |
Histone deacetylase |
HDX-MS |
Hydrogen-deuterium exchange MS |
HL |
Hodgkin lymphoma |
Hsp90 |
heat shock protein 90 |
LSD |
Lysine-specific demethylase |
MBD |
Methylated CpG-binding domain protein |
MiDAC |
Mitotic deacetylase |
MIDEAS |
Mitotic deacetylase-associated SANT domain |
MTA |
Metastasis tumor-associated protein |
NCoR |
Nuclear receptor corepressor |
NMPA |
National Medical Products Administration |
NMR |
Nuclear magnetic resonance |
NuRD |
Nucleosome remodeling and deacetylase |
PTMs |
Post-translational modifications |
QM/MM |
Quantum mechanical/molecular mechanical |
RBBP |
Retinoblastoma-binding protein |
SAHA |
Suberoylanilide hydroxamic acid |
SAP30 |
Sin3-associated protein p30 |
SAXS |
Small-angle X-ray scattering |
Sin3 |
Switch intensive 3 |
SIRT |
Sirtuin |
SMRT |
Silencing mediator of retinoic acid and thyroid hormone receptors |
STAT3 |
Signal transducers and activators of transcription 3 |
SUD3 |
Suppressor of defective silencing 3 |
TBL1 |
Transducin beta-like 1 |
XL-MS |
Chemical crosslinking mass spectrometry |
ZBG |
Zinc binding group |